ABD Dermatopathology

The ABD exam calendar lists two upcoming administrations: September 13 through October 1, 2027, and September 11 through September 29, 2028. Each is shown as a multi-day window rather than a single test date, so confirm your assigned day, application deadlines, and seat availability with the ABD before making travel or scheduling commitments.

The ABD page reviewed does not state an item count or a time limit for the dermatopathology subspecialty exam. Rather than relying on secondhand figures that may reflect older exam versions, check the ABD exam calendar and contact the board directly for the current structure before you build a timed practice plan.

No passing standard is published on the page reviewed, so this cannot be stated reliably here. Passing standards are set by the board and can be revised between administrations. Treat any specific cut score you encounter online as unverified, and request the current standard from the ABD before you interpret practice-test performance.

The fee is not listed on the ABD page reviewed, so no dollar figure is offered here. Fees can differ by application window, late-registration status, and candidate category. Contact the ABD for the current fee schedule and refund terms before you submit an application or budget for the cycle.

Retake rules are not described in the source material reviewed, so the number of attempts, waiting periods, and any reapplication requirements remain unconfirmed. Ask the ABD directly about the retake policy, and confirm whether a failed attempt affects your eligibility window before you plan a repeat sitting.

No pass rate is published on the page reviewed, so difficulty cannot be quantified honestly. The exam is a subspecialty-level assessment, meaning it assumes working fluency rather than trainee-level familiarity. Most candidates find the challenge lies in speed and consistency across thousands of diagnostic patterns, not in isolated esoteric facts.

Start with pattern recognition: interface, spongiotic, psoriasiform, vesiculobullous, granulomatous, and vasculopathic templates. Then layer melanocytic lesions, which carry the highest diagnostic risk, followed by keratinocytic and adnexal tumors, lymphoid and histiocytic infiltrates, and finally soft tissue, vascular, and neural entities. Finish by integrating immunohistochemistry and immunofluorescence into each pattern rather than studying stains in isolation.

Candidates typically lose points by pattern-shopping instead of committing to a morphologic diagnosis, by underusing ancillary stains, and by misjudging melanoma mimics in both directions. Weaknesses also cluster in lymphoid infiltrates and soft tissue tumors, which are studied last and least. Timed unknown-slide review with written commitments exposes these gaps faster than rereading textbooks.

The American Board of Dermatology lists its office at 2 Wells Avenue, Newton, Massachusetts 02459, with office hours Monday through Friday, 8:00 a.m. to 4:30 p.m. ET. The published phone and fax number is (617) 910-6400, and the general email is [email protected]. Verify all exam logistics there rather than through third-party summaries.

No. This is independent study material produced by a separate platform and is not reviewed, endorsed, or sponsored by the ABD. The ABD is the certifying body and the authoritative source for dates, eligibility, fees, and scoring. Always confirm exam logistics on abderm.org before relying on any third-party page, including this one.